Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
{{output}}
Background: The predictive value of tumor-infiltrating lymphocytes (TILs) in immune-related adverse event (irAE) development remains unknown, although an association between tumor immunogenicity and irAEs has been suggested. We i... ...
